These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23542493)

  • 1. In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration.
    Kürti L; Gáspár R; Márki Á; Kápolna E; Bocsik A; Veszelka S; Bartos C; Ambrus R; Vastag M; Deli MA; Szabó-Révész P
    Eur J Pharm Sci; 2013 Sep; 50(1):86-92. PubMed ID: 23542493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.
    Bartos C; Ambrus R; Sipos P; Budai-Szűcs M; Csányi E; Gáspár R; Márki Á; Seres AB; Sztojkov-Ivanov A; Horváth T; Szabó-Révész P
    Int J Pharm; 2015 Aug; 491(1-2):198-207. PubMed ID: 26142244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for rapid development of nasal delivery of analgesics--identification of relevant features, in vitro screening and in vivo verification.
    Wang S; Chow MS; Zuo Z
    Int J Pharm; 2011 Nov; 420(1):43-50. PubMed ID: 21871544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration.
    Agarwal V; Alayoubi A; Siddiqui A; Nazzal S
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1681-9. PubMed ID: 23072611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of solubility enhancement on nasal absorption of meloxicam.
    Horváth T; Ambrus R; Völgyi G; Budai-Szűcs M; Márki Á; Sipos P; Bartos C; Seres AB; Sztojkov-Ivanov A; Takács-Novák K; Csányi E; Gáspár R; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():96-102. PubMed ID: 27260088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.
    Aghazadeh-Habashi A; Jamali F
    Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved absorption of meloxicam via salt formation with ethanolamines.
    Han HK; Choi HK
    Eur J Pharm Biopharm; 2007 Jan; 65(1):99-103. PubMed ID: 16919925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.
    Ochi M; Kawachi T; Toita E; Hashimoto I; Yuminoki K; Onoue S; Hashimoto N
    Int J Pharm; 2014 Oct; 474(1-2):151-6. PubMed ID: 25138254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability.
    Radia O; Rogalska E; Moulay-Hassane G
    Pharm Dev Technol; 2012; 17(5):632-7. PubMed ID: 21428700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
    Khachane P; Date AA; Nagarsenker MS
    J Biomed Nanotechnol; 2011 Aug; 7(4):590-7. PubMed ID: 21870464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
    Ochi M; Inoue R; Yamauchi Y; Yamada S; Onoue S
    Pharm Res; 2013 Feb; 30(2):377-86. PubMed ID: 22983645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenously and orally administered meloxicam in sheep.
    Stock ML; Coetzee JF; KuKanich B; Smith BI
    Am J Vet Res; 2013 May; 74(5):779-83. PubMed ID: 23627392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.
    Pallagi E; Ambrus R; Szabó-Révész P; Csóka I
    Int J Pharm; 2015 Aug; 491(1-2):384-92. PubMed ID: 26134895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of meloxicam in koalas (Phascolarctos cinereus) after intravenous, subcutaneous and oral administration.
    Kimble B; Black LA; Li KM; Valtchev P; Gilchrist S; Gillett A; Higgins DP; Krockenberger MB; Govendir M
    J Vet Pharmacol Ther; 2013 Oct; 36(5):486-93. PubMed ID: 23406022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
    Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
    AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oral gabapentin alone or co-administered with meloxicam in ruminant beef calves.
    Coetzee JF; Mosher RA; Kohake LE; Cull CA; Kelly LL; Mueting SL; KuKanich B
    Vet J; 2011 Oct; 190(1):98-102. PubMed ID: 20869892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.